GlaxoSmithKline PLC (GSK.L)
1,712.50GBp
12:11pm EDT
28.50p (+1.69%)
1,684.00p
1,681.50p
1,712.50p
1,680.50p
5,967,343
6,703,631
1,816.00p
1,314.00p
About
Overall
| Beta: | 0.47 |
| Market Cap (Mil.): | £82,665.84 |
| Shares Outstanding (Mil.): | 4,908.90 |
| Dividend: | 18.00 |
| Yield (%): | 4.51 |
Financials
| GSK.L | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 20.80 | 37.93 | 37.76 |
| EPS (TTM): | 0.81 | -- | -- |
| ROI: | 15.19 | 19.48 | 18.76 |
| ROE: | 59.84 | 20.17 | 19.59 |
Drugmakers fear short-term 'turmoil' as China probes widen
LONDON/PARIS - Chinese authorities visited a regional office of French drugmaker Sanofi this week in the latest sign of a widening investigation into Western drugmakers.
RPT-INSIGHT-Corporate sleuths on edge after China detains foreign consultants
* Foreign couple's firm did work for GlaxoSmithKline, other drugmakers
Insight: Corporate sleuths on edge after China detains foreign consultants
SHANGHAI - The detention by Chinese authorities of a British corporate investigator and his American wife in the wake of a corruption probe into pharmaceutical giant GlaxoSmithKline has had a chilling effect on other risk consultants working in China. | Video
RPT-INSIGHT-Corporate sleuths on edge after China detains foreign consultants
* Foreign couple's firm did work for GlaxoSmithKline, other drugmakers
INSIGHT-Corporate sleuths on edge after China detains foreign consultants
* Foreign couple's firm did work for GlaxoSmithKline, other drugmakers
Analysis: Bayer immune to pharma's breakup bug?
FRANKFURT - Investors banking on Bayer to embrace a trend in the pharma sector to split off non-core units may be too far ahead of the curve.
UPDATE 2-China state media says 18 more detained in GSK probe
BEIJING, July 27 - At least 18 more people have been detained in China in connection with a corruption scandal involving British drugmaker GlaxoSmithKline, state media reported, giving more details on an investigation that has rocked the company.
China state media says 18 more detained in GSK probe
BEIJING - At least 18 more people have been detained in China in connection with a corruption scandal involving British drugmaker GlaxoSmithKline, state media reported, giving more details on an investigation that has rocked the company.
China state media says 18 more detained in GSK probe
BEIJING - At least 18 more people have been detained in China in connection with a corruption scandal involving British drugmaker GlaxoSmithKline, state media reported, giving more details on a probe which has rocked the company.
Why China pays too much for medicines
- China has a drug problem. While most Western countries spend 10-12 percent of their healthcare budget on medicines, in China it is well over 40 percent, a disparity that goes to the heart of Beijing's crackdown on the industry.
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: Wright Reports
|
$483.00
|
|
Provider: Plunkett Research, Ltd.
|
$99.00
|
|
Provider: S&P Capital IQ – STARS Reports
|
$127.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

